Day Return
YTD Return
1-Year Return
3-Year Return
5-Year Return
Note: Sector performance is calculated based on the previous closing price of all sector constituents
Industries in This Sector
Select an Industry for a Visual Breakdown
| Industry | Market Weight | YTD Return | |
|---|---|---|---|
| All Industries | 100.00% | 5.75% | |
| Drug Manufacturers - General | 34.15% | 11.84% | |
| Healthcare Plans | 13.29% | -2.08% | |
| Medical Devices | 12.66% | 5.42% | |
| Diagnostics & Research | 11.65% | 7.85% | |
| Biotechnology | 11.49% | -0.97% | |
| Medical Instruments & Supplies | 6.60% | 5.44% | |
| Medical Care Facilities | 2.90% | 13.23% | |
| Drug Manufacturers - Specialty & Generic | 2.75% | -2.84% | |
| Medical Distribution | 2.27% | 7.19% | |
| Health Information Services | 2.01% | 4.54% | |
| Pharmaceutical Retailers | 0.22% | -35.64% | |
Note: Percentage % data on heatmap indicates Day Return
All Industries
-
Largest Companies in This Sector
|
Name
|
Last Price
|
1Y Target Est.
|
Market Weight
|
Market Cap
|
Day Change %
|
YTD Return
|
Avg. Analyst Rating
|
|---|---|---|---|---|---|---|---|
| 803.17 | 858.83 | 11.57% |
|
|
|
Buy
|
|
| 523.55 | 567.48 | 7.41% |
|
|
|
Buy
|
|
| 151.24 | 158.52 | 5.52% |
|
|
|
Buy
|
|
| 130.76 | 129.79 | 5.03% |
|
|
|
Buy
|
|
| 162.93 | 183.11 | 4.41% |
|
|
|
Buy
|
|
| 590.12 | 624.17 | 3.44% |
|
|
|
Buy
|
|
| 266.55 | 271.39 | 3.00% |
|
|
|
Buy
|
|
| 102.96 | 126.23 | 2.72% |
|
|
|
Buy
|
|
| 314.85 | 290.81 | 2.56% |
|
|
|
Buy
|
|
| 28.56 | 28.89 | 2.45% |
|
|
|
Buy
|
Investing in the Healthcare Sector
Start Investing in the Healthcare Sector Through These ETFs and Mutual Funds
ETF Opportunities
|
Name
|
Last Price
|
Net Assets
|
Expense Ratio
|
YTD Return
|
|---|---|---|---|---|
| 146.25 | 37.936B | 0.09% |
|
|
| 266.91 | 20.002B | 0.10% |
|
|
| 136.91 | 6.991B | 0.45% |
|
|
| 91.57 | 6.358B | 0.35% |
|
|
| 56.36 | 5.241B | 0.40% |
|
Mutual Fund Opportunities
|
Name
|
Last Price
|
Net Assets
|
Expense Ratio
|
YTD Return
|
|---|---|---|---|---|
| 217.13 | 45.706B | 0.29% |
|
|
| 91.56 | 45.706B | 0.29% |
|
|
| 133.53 | 20.002B | 0.10% |
|
|
| 92.74 | 15.399B | 0.80% |
|
|
| 93.95 | 14.487B | 0.80% |
|
Healthcare Research
Discover the Latest Analyst and Technical Research for This Sector
-
Analyst Report: AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.
RatingPrice Target -
Analyst Report: Zimmer Biomet Holdings Inc
Based in Warsaw, Indiana, Zimmer Biomet is the nation's largest pure-play maker of orthopedic devices. The current company arose from the 2015 merger of Zimmer and Biomet, both were headquartered in Warsaw, Indiana. The company designs, develops and manufactures reconstructive orthopedic implants; sports injury repair and trauma products; and related orthopedic surgical products. Its primary customers include musculoskeletal surgeons, neurosurgeons, hospitals, distributors, and, in their capacity as agents, healthcare purchasing organizations or buying groups. ZBH shares are a component of the S&P 500.
RatingPrice Target -
Daily – Vickers Top Insider Picks for 05/21/2024
The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
-
Daily – Vickers Top Buyers & Sellers for 05/21/2024
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
